DOSE FINDING STUDY OF PF-05212384 WITH PACLITAXEL AND CARBOPLATIN IN PATIENTS WITH ADVANCED SOLID TUMOR
Phase of Trial: Phase I
Latest Information Update: 22 May 2019
Price : $35 *
At a glance
- Drugs Gedatolisib (Primary) ; Carboplatin; Paclitaxel
- Indications Advanced breast cancer; Endometrial cancer; Head and neck cancer; Non-small cell lung cancer; Ovarian cancer; Small cell lung cancer; Solid tumours
- Focus Adverse reactions
- 20 May 2019 Status changed from active, no longer recruiting to completed.
- 26 Nov 2018 Status changed from recruiting to active, no longer recruiting.
- 31 Aug 2018 Biomarkers information updated